Rocket Pharmaceuticals (RCKT) Acquisitions (2018)
Rocket Pharmaceuticals (RCKT) posted Acquisitions of $76.3 million for Q1 2018.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Acquisitions (2018) Analysis & Trends
Rocket Pharmaceuticals has reported Acquisitions for 1 years, with the latest figure at $76.3 million in Q1 2018.
- Quarterly Acquisitions changed N/A year-over-year to $76.3 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $76.3 million (changed N/A YoY) and the FY2022 annual result came in at $42.7 million, changed N/A from the prior year.
- Acquisitions held at $76.3 million in Q1 2018 per RCKT's latest filing.
- Over five years, Acquisitions peaked at $76.3 million in Q1 2018 and troughed at $76.3 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Rocket Pharmaceuticals | 437.27 Mn | 437.27 Mn | - | - |